Recombinant Human PegIFNα2a Protein, GMP Grade
Product Specifications
eClass Product Group
Protein
Origin
Human
Applications
The product is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies. The product is also indicated as a monotherapy for adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who havecompensated liver disease and evidence of viral replication and liver inflammation.
Shipping Conditions
Ice packs
Product Datasheet
https://cdn.gentaur.com/products/501/6867f79c994c49e6dc690289/datasheet/pegifnα2a-167thp.pdf
CAS Number
9000-83-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1413872 Inquire
Recombinant Roseobacter denitrificans Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial
Ask
View Details